United Kingdom Neurology Devices Market Outlook to 2025 – Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others.

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

“What is covered in the report about the “United Kingdom Neurology Devices Market”?
GlobalData’s “United Kingdom Neurology Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United Kingdom Neurology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Hydrocephalus shunts , Interventional Neuroradiology, Minimally Invasive Neurosurgery, Neurological Diagnostic and Monitoring Equipment, Neuromodulation Devices, Neurosurgical Products and Radiosurgery Systems.

The United Kingdom Neurology Devices Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Neurology Devices market.
• Global corporate-level profiles of key companies operating within the United Kingdom Neurology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

United Kingdom Neurology Devices is segmented as follows:
• Hydrocephalus shunts
• Interventional Neuroradiology
• Minimally Invasive Neurosurgery
• Neurological Diagnostic and Monitoring Equipment
• Neuromodulation Devices
• Neurosurgical Products
• Radiosurgery Systems

Key Reasons to Purchase
The United Kingdom Neurology Devices Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United Kingdom Neurology Devices Market Outlook to 2025” report
• Boston Scientific Corp
• Medtronic plc
• Stryker Corp

The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 3,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 66.956+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 2,000+ quarterly and annual medical equipment company financials
• 1,100+ medical equipment company SWOTs
• 26,400+ pipeline product profiles
• 52,400+ marketed product profiles
• 44,600+ clinical trials
• 52,400+ trial investigators
• 7,900+ reports on companies with products in development
• 42,000+ deals in the medical equipment industry
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx

Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 12

2.1 What Is This Report About? 12

2.2 Neurology Devices Market Segmentation 12

2.3 Definitions of Markets Covered in the Report 14

3 Neurology Devices Market, United Kingdom 21

3.1 Neurology Devices Market, United Kingdom, Revenue ($m), 2015-2025 21

3.2 Neurology Devices Market, United Kingdom, Revenue Mix ($m), 2018 23

3.3 Neurology Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2018 24

3.4 Neurology Devices Market, United Kingdom, Revenue ($m), 2015-2025 26

3.5 Neurology Devices Market, United Kingdom, Volume (Units), 2015-2025 29

3.6 Neurology Devices Market, United Kingdom, Volume (Units), 2015-2025 31

3.7 Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), 2018 34

4 Hydrocephalus shunts Market, United Kingdom 36

4.1 Hydrocephalus shunts Market, United Kingdom, Revenue Mix ($m), 2018 36

4.2 Hydrocephalus shunts Market, United Kingdom, Segment Contribution (%), 2018 37

4.3 Hydrocephalus shunts Market, United Kingdom, Revenue ($m), 2015-2025 38

4.3.1 Hydrocephalus Catheters Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 40

4.3.2 Hydrocephalus Valves Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 42

4.4 Hydrocephalus shunts Market, United Kingdom, Volume (Units), 2015-2025 44

4.4.1 Hydrocephalus Catheters Market, United Kingdom, Volume (Units), by Segment, 2015-2025 46

4.4.2 Hydrocephalus Valves Market, United Kingdom, Volume (Units), by Segment, 2015-2025 48

4.5 Hydrocephalus shunts Market, United Kingdom, Average Price ($), 2015-2025 50

4.6 Hydrocephalus shunts Market, United Kingdom, Distribution Share by Revenue ($m), 2018 51

4.7 Hydrocephalus shunts Market, United Kingdom, Company Share by Revenue ($m), 2018 52

5 Interventional Neuroradiology Market, United Kingdom 54

5.1 Interventional Neuroradiology Market, United Kingdom, Revenue Mix ($m), 2018 54

5.2 Interventional Neuroradiology Market, United Kingdom, Segment Contribution (%), 2018 55

5.3 Interventional Neuroradiology Market, United Kingdom, Revenue ($m), 2015-2025 56

5.3.1 Neurovascular Accessory Devices Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 59

5.3.2 Neurovascular Coiling Assist Devices Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 61

5.3.3 Neurovascular Embolization Devices Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 63

5.3.4 Neurovascular Thrombectomy Devices Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 66

5.4 Interventional Neuroradiology Market, United Kingdom, Volume (Units), 2015-2025 68

5.4.1 Neurovascular Accessory Devices Market, United Kingdom, Volume (Units), by Segment, 2015-2025 71

5.4.2 Neurovascular Coiling Assist Devices Market, United Kingdom, Volume (Units), by Segment, 2015-2025 73

5.4.3 Neurovascular Embolization Devices Market, United Kingdom, Volume (Units), by Segment, 2015-2025 75

5.4.4 Neurovascular Thrombectomy Devices Market, United Kingdom, Volume (Units), by Segment, 2015-2025 78

5.5 Interventional Neuroradiology Market, United Kingdom, Average Price ($), 2015-2025 80

5.6 Interventional Neuroradiology Market, United Kingdom, Distribution Share by Revenue ($m), 2018 82

5.7 Interventional Neuroradiology Market, United Kingdom, Company Share by Revenue ($m), 2018 83

6 Minimally Invasive Neurosurgery Market, United Kingdom 85

6.1 Minimally Invasive Neurosurgery Market, United Kingdom, Revenue ($m), 2015-2025 85

6.1.1 Minimally Invasive Neurosurgical Devices Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 87

6.2 Minimally Invasive Neurosurgery Market, United Kingdom, Volume (Units), 2015-2025 89

6.2.1 Minimally Invasive Neurosurgical Devices Market, United Kingdom, Volume (Units), by Segment, 2015-2025 91

6.3 Minimally Invasive Neurosurgery Market, United Kingdom, Average Price ($) , 2015-2025 93

6.4 Minimally Invasive Neurosurgery Market, United Kingdom, Distribution Share by Revenue ($m), 2018 94

6.5 Minimally Invasive Neurosurgery Market, United Kingdom, Company Share by Revenue ($m), 2018 95

7 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom 97

7.1 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Revenue Mix ($m), 2018 97

7.2 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Segment Contribution (%), 2018 98

7.3 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Revenue ($m), 2015-2025 99

7.3.1 Electrical Activity Testing Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 101

7.3.2 ICP Monitoring Devices Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 103

7.4 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Volume (Units), 2015-2025 105

7.4.1 Electrical Activity Testing Market, United Kingdom, Volume (Units), by Segment, 2015-2025 107

7.4.2 ICP Monitoring Devices Market, United Kingdom, Volume (Units), by Segment, 2015-2025 109

7.5 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Average Price ($), 2015-2025 111

7.6 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Distribution Share by Revenue ($m), 2018 113

7.7 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Company Share by Revenue ($m), 2018 114

8 Neuromodulation Devices Market, United Kingdom 116

8.1 Neuromodulation Devices Market, United Kingdom, Revenue Mix ($m), 2018 116

8.2 Neuromodulation Devices Market, United Kingdom, Segment Contribution (%), 2018 117

8.3 Neuromodulation Devices Market, United Kingdom, Revenue ($m), 2015-2025 119

8.4 Neuromodulation Devices Market, United Kingdom, Volume (Units), 2015-2025 122

8.5 Neuromodulation Devices Market, United Kingdom, Average Price ($), 2015-2025 125

8.6 Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2018 127

8.7 Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2018 128

9 Neurosurgical Products Market, United Kingdom 130

9.1 Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2018 130

9.2 Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2018 131

9.3 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2015-2025 132

9.3.1 Dura Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 134

9.3.2 Neuroendoscopes Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 136

9.3.3 Neurosurgical Drills Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 138

9.4 Neurosurgical Products Market, United Kingdom, Volume (Units), 2015-2025 140

9.4.1 Dura Substitutes Market, United Kingdom, Volume (Units), by Segment, 2015-2025 142

9.4.2 Neuroendoscopes Market, United Kingdom, Volume (Units), by Segment, 2015-2025 144

9.4.3 Neurosurgical Drills Market, United Kingdom, Volume (Units), by Segment, 2015-2025 146

9.5 Neurosurgical Products Market, United Kingdom, Average Price ($) , 2015-2025 148

9.6 Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), 2018 150

9.7 Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), 2018 151

10 Radiosurgery Systems Market, United Kingdom 153

10.1 Radiosurgery Systems Market, United Kingdom, Revenue ($m), 2015-2025 153

10.2 Radiosurgery Systems Market, United Kingdom, Volume (Units), 2015-2025 155

10.3 Radiosurgery Systems Market, United Kingdom, Average Price ($), 2015-2025 157

11 Overview of Key Companies in United Kingdom, Neurology Devices Market 158

11.1 Medtronic Plc 158

11.1.1 Company Overview 158

11.2 Natus Medical Incorporated 158

11.2.1 Company Overview 158

11.3 Stryker Corp 158

11.3.1 Company Overview 158

11.4 Penumbra Inc 159

11.4.1 Company Overview 159

11.5 B. Braun Melsungen AG 159

11.5.1 Company Overview 159

11.6 MicroVention Inc 159

11.6.1 Company Overview 159

11.7 Boston Scientific Corp 159

11.7.1 Company Overview 159

11.8 Abbott Laboratories 160

11.8.1 Company Overview 160

11.9 Nihon Kohden Corp 160

11.9.1 Company Overview 160

11.10 Nevro Corp 160

11.10.1 Company Overview 160

11.11 LivaNova PLC 160

11.11.1 Company Overview 160

11.12 Integra LifeSciences Corp 161

11.12.1 Company Overview 161

11.13 CERENOVUS 161

11.13.1 Company Overview 161

12 Neurology Devices Market Pipeline Products 162

13 Financial Deals Landscape 167

13.1 Venture Financing 167

13.1.1 Neurovalens Raises USD0.94 Million in Financing Round 167

13.1.2 Cerus Endovascular Raises Additional USD4.5 Million in Venture Financing 168

13.1.3 Psyomics Raises Funds through Seed Financing 169

13.1.4 Neurovalens Raises USD6 Million in Series A Financing 170

13.1.5 Belluscura Raises USD0.6 Million in Funding 172

14 Recent Developments 173

14.1 Corporate Communications 173

14.1.1 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 173

14.1.2 Sep 10, 2019: Fraunhofer ITEM committed to simplifying the testing and increasing the safety of medical devices in the EU Project MDOT 173

14.1.3 Aug 22, 2019: IXICO announces directorate changes 174

14.1.4 Aug 19, 2019: IXICO announces revenue and EBITDA for full year 2019 expected to be ahead of market expectations 174

14.1.5 Aug 12, 2019: GSK announces leadership changes in the US 174

14.1.6 Jul 24, 2019: GlaxoSmithKline appoints Jonathan Symonds as Non-Executive Chairman of the Board of Directors 175

14.1.7 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 175

14.1.8 Jul 24, 2019: GlaxoSmithKline appoints Jonathan Symonds as Non-Executive Chairman of the Board of Directors 176

14.1.9 Jul 23, 2019: Flow raises $1.5m for brain stimulation depression treatment 176

14.1.10 Jul 01, 2019: Cambridge Cognition Holdings: Appointment of Non-Executive Director 177

14.1.11 Jun 24, 2019: Trevena announces publication of APOLLO-2 results in pain practice 177

14.1.12 Jun 19, 2019: LivaNova welcomes Stacy Enxing Seng to Board of Directors 178

14.1.13 May 23, 2019: Cambridge Cognition Holdings: Result of AGM and board changes 178

14.1.14 Apr 25, 2019: Cambridge Cognition Holdings: Board changes 179

14.1.15 Mar 28, 2019: GlaxoSmithKline Pharmaceuticals: Change in directorate 179

14.1.16 Mar 18, 2019: LivaNova announces Trui Hebbelinck as Chief Human Resources Officer 180

14.1.17 Mar 07, 2019: Cambridge Cognition Holdings: Appointment of Chief Operating Officer 180

14.1.18 Mar 04, 2019: California Life Sciences Association (CLSA) adds GlaxoSmithKline and Blade Therapeutics to Board 181

14.1.19 Feb 12, 2019: Sanofi names Ameet Nathwani as chief digital officer 181

14.1.20 Feb 07, 2019: IXICO: Appointment of chief financial officer 182

14.1.21 Jan 21, 2019: GlaxoSmithKline announces resignation of Sir Philip Hampton as non-executive chairman 182

14.1.22 Jan 21, 2019: GSK announces succession plan to appoint new Chairman 183

14.2 Financial Announcements 183

14.2.1 Oct 30, 2019: LivaNova reports third quarter 2019 results 183

14.2.2 Oct 15, 2019: IXICO: Trading Update for year ended 30 September 2019 184

14.2.3 Jul 31, 2019: LivaNova reports second quarter 2019 results 184

14.2.4 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 185

14.2.5 Jul 24, 2019: GSK delivers sales and earnings growth in Q2 2019 187

14.2.6 Jul 17, 2019: AorTech International: Final results for the year ended 31 March 2019 187

14.2.7 May 22, 2019: IXICO: Half yearly report to 31 March 2019 190

14.2.8 May 01, 2019: Smith & Nephew adopts one-platform approach with Medidata to support expansion of study portfolio 195

14.2.9 May 01, 2019: LivaNova announces first quarter 2019 results 197

14.2.10 May 01, 2019: GSK delivers sales of £7.7 billion +6% AER, +5% CER 198

14.2.11 Apr 18, 2019: Zuellig Pharma, NICVB and NIHE announce project to expand access to vaccines in Vietnam through the use of innovative eZCooler technology 198

14.2.12 Apr 05, 2019: LivaNova reports preliminary unaudited first quarter 2019 revenue results 201

14.2.13 Mar 07, 2019: Cambridge Cognition Holdings: Preliminary Results for the year ended 31 December 2018 201

14.2.14 Feb 27, 2019: LivaNova reports fourth quarter and full-year 2018 results 204

14.2.15 Feb 26, 2019: Axogen announces 2018 fourth quarter and full year 2018 financial results 206

14.2.16 Feb 06, 2019: GSK delivers sales, earnings and cash flow growth in 2018 207

14.3 Government and Public Interest 208

14.3.1 Aug 29, 2019: Deep learning unpacks benefits of psychotherapy 208

14.3.2 Jun 20, 2019: Parkinson’s disease: serotonin link discovery could lead to new screening tools 208

14.3.3 Jun 05, 2019: Nearly three quarters of a million patients set to benefit from world-leading innovations on the NHS 209

14.4 Legal And Regulatory 210

14.4.1 Sep 13, 2019: Vectura provides update on GSK Litigation 210

14.4.2 Jul 16, 2019: Swiss agree to extradite Chinese researcher in US corporate espionage case 211

14.4.3 May 04, 2019: Vectura wins US GSK Patent Litigation and awarded $89.7Million in damages by Trial Jury 211

14.4.4 Feb 15, 2019: BRAVO BIDCO: Update on the proposed acquisition of BTG 212

14.4.5 Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences 212

14.5 Other Significant Developments 212

14.5.1 Oct 28, 2019: IXICO announces client contracts and appointment of Chief Business Officer 212

14.5.2 Aug 09, 2019: IXICO provides an update on new and current contracts 213

14.5.3 Aug 08, 2019: Sareum notes Sierra Oncology has reported its second quarter 2019 results and published its Form 10-Q with the US SEC 213

14.5.4 Aug 07, 2019: Smartphone test predicts how symptoms develop in Parkinson’s 214

14.5.5 Jul 29, 2019: UCD researcher and CÚRAM investigator awarded ERC proof of concept funding 215

14.5.6 Jul 16, 2019: Oventus executes material agreements in the US to enable widespread adoption of ‘lab in lab’ model in sleep and dental channels 216

14.5.7 Jul 14, 2019: RaySearch and Vision RT announce strategic partnership 218

14.5.8 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility 218

14.5.9 May 14, 2019: AorTech International: Trading update 218

14.5.10 Apr 25, 2019: IXICO: Trading update for the first half of financial year ending 31 March 2019 219

14.5.11 Mar 28, 2019: GSK publishes product sales reporting changes and the impact of IFRS 16 'Leases' 220

14.5.12 Mar 19, 2019: Cambridge Cognition Holdings: £1.3m digital health contract win 221

14.5.13 Mar 12, 2019: GlaxoSmithKline: Publication of 2018 annual report 221

14.5.14 Mar 11, 2019: New genetic data from Regeneron and GSK on 50,000 UK Biobank participants made available to global health research community 236

14.5.15 Jan 31, 2019: Cambridge Cognition Holdings: First partnership in India and new product launch 237

14.5.16 Jan 24, 2019: AorTech International: Company Update 238

14.6 Product News 239

14.6.1 May 20, 2019: Researchers develop new method to understand ALS 239

14.6.2 Mar 26, 2019: Rogue Resolutions are proud to announce partnership with the European Neuro Convention at the NEC Birmingham 239

14.6.3 Mar 09, 2019: MRC-funded study suggests deep brain stimulation could help OCD symptoms 240

14.7 Strategy And Business Planning 241

14.7.1 Nov 07, 2019: Medopad partners with Janssen on digital memory test 241

14.7.2 Jun 21, 2019: GSK to raise $1.26bn by selling consumer health brands 241

15 Appendix 243

15.1 Research Methodology 244

15.1.1 Coverage 244

15.1.2 Secondary Research 244

15.1.3 Primary Research 245

15.1.4 Market Modeling and Forecasting 246

15.1.5 Company Share Analysis 247

15.1.6 Distribution Share Analysis 248

15.1.7 Benchmarking 248

15.2 GlobalData Consulting 249

15.3 Contact Us 249

15.4 Disclaimer 249

Frequently asked questions

United Kingdom Neurology Devices Market Outlook to 2025 – Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. thematic reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United Kingdom Neurology Devices Market Outlook to 2025 – Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. in real time.

  • Access a live United Kingdom Neurology Devices Market Outlook to 2025 – Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.